FTC Probes Mylan Over Provigil Settlements
Looking to regulate the possible anti-competitive effects of deals that keep generic drug alternatives off the market, the Federal Trade Commission is investigating Mylan Laboratories Inc.'s patent litigation settlement related to...To view the full article, register now.
Already a subscriber? Click here to view full article